These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [TBL] [Abstract][Full Text] [Related]
4. Management of rheumatoid arthritis. Handa R Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402 [TBL] [Abstract][Full Text] [Related]
5. The role of anti-malarials in rheumatoid arthritis--the American experience. Khraishi MM; Singh G Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910 [TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis: new concepts in disease evolution, pathogenesis, and treatment. Paget SA Semin Arthroplasty; 1995 Jul; 6(3):132-44. PubMed ID: 10163520 [No Abstract] [Full Text] [Related]
11. Medical treatment of rheumatoid arthritis. Caldwell JR J Fla Med Assoc; 1995 May; 82(5):343-7. PubMed ID: 7602306 [TBL] [Abstract][Full Text] [Related]
12. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis]. Cervini C; Salaffi F; Peroni M Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508 [TBL] [Abstract][Full Text] [Related]
13. Leflunomide for rheumatoid arthritis. Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115 [TBL] [Abstract][Full Text] [Related]
14. [The role of the conventional drugs in the treatment of rheumatoid arthritis]. Fantini F Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241 [TBL] [Abstract][Full Text] [Related]
15. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug. Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154 [TBL] [Abstract][Full Text] [Related]
16. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial. Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing length of time taking methotrexate in rheumatoid arthritis. Ortendahl M; Schettler JD; Fries JF J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279 [TBL] [Abstract][Full Text] [Related]
18. Aggressive treatment of early rheumatoid arthritis to prevent joint damage. Pincus T Bull Rheum Dis; 1998 Dec; 47(8):2-7. PubMed ID: 9926484 [No Abstract] [Full Text] [Related]
19. [ACR preliminary definition, of improvement in rheumatoid arthritis]. Homma M Ryumachi; 1996 Dec; 36(6):891-900. PubMed ID: 9122830 [No Abstract] [Full Text] [Related]
20. Diagnosis and management of rheumatoid arthritis. Rindfleisch JA; Muller D Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]